Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 73,368 shares at $35.17 ($2.6M) on 2024-10-17, disclosed to the SEC on 2024-10-18.
Scheduled sale ($2.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.35 | 23,671 | $837K | 32.3% |
| 2 | $35.35 | 23,671 | $837K | 32.3% |
| 3 | $35.17 | 13,013 | $458K | 17.7% |
| 4 | $35.17 | 13,013 | $458K | 17.7% |
| Total | $35.29 avg | 73,368 | $2.6M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |